Pharma Services July 2023
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Genpro Research Inc. was acquired by Catalyst Clinical Research, LLC
- Alcanza Clinical Research, LLC announced its acquisition of Accel Research Sites
- Recursion Pharmaceuticals, Inc. (NasdaqGS:RXRX) closed a $50MM Series A Financing, led by NVIDIA Corporation (NasdaqGS:NVDA)